Arkolith/Insider Trading/BPSR/Form 4

Bothwell Ian T

Chief Financial Officer, Director, 10% OwnerOrganicell Regenerative Medicine, Inc. (BPSR) · full profile →Form 4 · filed Nov 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 29, 2021Other(J)15.0M——133.0M
Oct 29, 2021Other(J)15.0M——148.0M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-21-005202) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML